Cite
Role of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy.
MLA
Challa, Vasu Reddy, et al. “Role of Fluorine-18-Labeled 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography-Computed Tomography in the Evaluation of Axillary Lymph Node Involvement in Operable Breast Cancer in Comparison with Sentinel Lymph Node Biopsy.” Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India, vol. 28, no. 3, July 2013, pp. 138–43. EBSCOhost, https://doi.org/10.4103/0972-3919.119542.
APA
Challa, V. R., Srivastava, A., Dhar, A., Parshad, R., Bal, C., Mohan Reddy Gona, R., Kumar, R., Datta Gupta, S., & Sharma, P. (2013). Role of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy. Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India, 28(3), 138–143. https://doi.org/10.4103/0972-3919.119542
Chicago
Challa, Vasu Reddy, Anurag Srivastava, Anita Dhar, Rajinder Parshad, Chandrasekhar Bal, Rama Mohan Reddy Gona, Rakesh Kumar, Siddhartha Datta Gupta, and Punit Sharma. 2013. “Role of Fluorine-18-Labeled 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography-Computed Tomography in the Evaluation of Axillary Lymph Node Involvement in Operable Breast Cancer in Comparison with Sentinel Lymph Node Biopsy.” Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India 28 (3): 138–43. doi:10.4103/0972-3919.119542.